Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Open Heart|February 3, 2016
Heart rate never lies: interventional cardiologist and Braude's quote revisedStéphane Cook, Jean-Christophe Stauffer, Jean-Jacques Goy, et al.
Archives of Cardiovascular Diseases|November 27, 2012
A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: the CLO-CLO trialMarkus Oberhänsli, Cédric Lehner, Serban Puricel, et al.
JACC. Case Reports|September 10, 2021
Chest Pain and Hemodynamic Instability in a Young WomanNikesh Raj Shrestha, Stéphane Cook, Jean-Jacques Goy
American Heart Journal|June 4, 2014
Ten-year clinical follow-up after sirolimus-eluting stent implantationNuno Palhais, Diego Arroyo, Sonja Lehmann, et al.
Open Heart|January 19, 2018
Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trialDiego A Arroyo, Sara Schukraft, Zacharenia Kallinikou, et al.
International Journal of Cardiology|October 7, 2015
Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT)Serban Puricel, Zacharenia Kallinikou, Jaqueline Espinola, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2021
Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffoldsSara Schukraft, Diego Arroyo, Mario Togni, et al.
International Journal of Cardiology|June 4, 2017
Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trialDiego Arroyo, Gregoire Gendre, Sara Schukraft, et al.
Trials|January 9, 2014
Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trialDiego Arroyo, Mario Togni, Serban Puricel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 17, 2014
A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)Serban Puricel, Diego Arroyo, Jean-Jacques Goy, et al.
Pageof 23